Month |
Publication |
Title |
| December |
The Economic Times |
Orchid Chemicals gets USFDA approval for divalproex tablets |
| October |
The Economic Times |
Orchid promoter raises stake to 23% |
| September |
Business Standard |
Orchid allies with Merck for drug discovery |
| September |
The Economic Times |
Orchid enters into $100 mn licensing agreement with Merck
|
| August |
The Economic Times |
Orchid Chemicals to develop an anti-coagulant drug |
| August |
The Economic Times |
Orchid Chem recieves EU approval for bacterial injection |
| July |
The Financial Express |
Orchid, Ranbaxy to finalise agreement next month |
| July |
The Financial Express |
Orchid receives nod for Piperacilin Tazobactam injections |
| July |
Business Standard |
Orchid gets permission to sell drug in Canada |
| June |
The Times of India |
Orchid founder to raise stake, convert warrants |
| April |
The Hindu |
Orchid Chemicals sets up subsidiary in Japan |
| April |
The Economic Times |
Orchid Chemicals sees $100 million sales from Japan in 5 years |
| February |
The Economic Times |
Orchid receives US FDA nod for non-antibiotic drug |
| February |
The Hindu |
New CSO for Orchid Chemicals |
| January |
The Economic Times |
Orchid Pharma net rises 91% |
